gbt stock price | BTCC Knowledge

gbt stock price pepe unchain Bnb Eth XRP crypto futures coinbase futures binance futures

How much did Global Blood Therapeutics (GBT) raise in an IPO?

Global Blood Therapeutics (GBT) raised $102 million in an IPO on Wednesday, August 12th 2015. The company issued 6,000,000 shares at $16.00-$18.00 per share. Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and Cowen and Company and Wedbush PacGrow were co-managers.

Did Pfizer buy Global Blood Therapeutics (GBT)?

Pfizer Inc. (NYSE:PFE) completed the acquisition of Global Blood Therapeutics, Inc. (NasdaqGS:GBT) from a group of shareholders. Executive Vice President of Operations exercised options to buy US$2.0m worth of stock. Return vs Industry: GBT exceeded the US Biotechs industry which returned -4.2% over the past year.

What is GBT & how does it work?

Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder.

Understanding Leverage And Margin In Crypto Trading: Best Cryptocurrency Leverage Trading Platforms In 20242024-12-06 13:30:27Donald Trump’s big win in the U.S. elections has sparke […]